Zymedi Announces "rapaprutug" as the International Nonproprietary Name (INN) for ZMA001
INCHEON, South Korea, Dec. 8, 2025 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy...
KT&G Rated Strongly by S&P and Moody's
- 'A-' by S&P, 'A3' by Moody's—Positive Factors Include Business Stability, Financial Stability, and Global Business Growth SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ -- On the 7th, KT&G Corporation ("KT&G") (KRX:033780), South...